Article Text
PDFLetter
Comment on: the influence of the pharmaceutical industry on the off-label use of its medicines
Statistics from Altmetric.com
Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or …
Read the full text or download the PDF:
Other content recommended for you
- Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
- Pharmaceutical industry funding of events for healthcare professionals on non-vitamin K oral anticoagulants in Australia: an observational study
- Monitoring, reporting and regulating medicine quality: tensions between theory and practice in Tanzania
- Spurious and counterfeit drugs: a growing industry in the developing world
- Evaluation of the decision-making process underlying the initial off-label use of vaccines: a scoping review protocol
- Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers
- Suitability of paediatric legislation beyond the USA and Europe: a qualitative study on access to paediatric medicines
- Unlicensed and off label drug use in paediatric wards: prospective study
- Unlicensed and off label drug use in neonates
- Off-label use of bevacizumab in the treatment of retinal disease: ethical implications